An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
news 3 hours ago

Jim Cramer's hopeful on Abbott Labs after court case win

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by hefty lawsuits.

Contact Us